Ebit Cambiamento Data
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -65.93M 17.65M 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 3.83B 130M 2026-03
Baxter International USD 276M 210M 2026-06
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cipla INR 8.88B 2.74B 2026-06
Dr.Reddys Laboratories INR 3.25B 2.36B 2026-06
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Incyte USD 700.4M 356.23M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
MacroGenics USD -31.88M 19.79M 2026-03
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Takeda JPY 201.42B 215.04B 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
Xencor USD -77.86M 24.23M 2026-03